- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05156957
Effect of Physiotherapy in Patients Presenting to the Emergency Department With Nonspecific Lower Back Pain (EPAC-II)
March 27, 2024 updated by: University Hospital, Basel, Switzerland
Effect of Physiotherapy in Patients Presenting to the Emergency Department With Nonspecific Lower Back Pain. A Brief Intervention Focusing on Patient Reported Outcomes
Physiotherapy is a long established therapy in lower back pain.
It is unknown if physiotherapeutic interventions in patients presenting to the Emergency Department (ED) with nonspecific lower back pain are beneficial.
The aim of this study is to assess whether patients presenting to the emergency department with non-specific low risk low back pain would benefit from a physiotherapy intervention, as compared to patients without physiotherapy intervention at time of ED presentation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
126
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Henk B. Riedel
- Phone Number: +41 61 556 53 24
- Email: Henk.Riedel@usb.ch, physiostudie@usb.ch
Study Locations
-
-
-
Basel, Switzerland, 4031
- Emergency Department University Hospital Basel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Written informed consent
- Experiencing nonspecific lower back pain
- Presentation to the Emergency Department (ED) of the University Hospital Basel
Exclusion Criteria:
- Inpatient disposition after ED work-up
"Red Flags" at time of ED-presentation:
- Major trauma in all patients
- Fractures leading to immobilization
- Severe or progressive sensory alteration or weakness
- Bladder or bowel dysfunction
- Evidence of neurological deficit on physical examination
- Severe chronic disease, such as metastasized cancer, palliative care
- Epidural steroid injections in the last 3 months
- Inability or contraindications to undergo the investigated intervention or to follow the study procedures, e.g. due to certain neurological disorders, language problems, psychological disorders, cognitive impairment, physical inability etc.
- Prior enrolment in this trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: intervention group
The study intervention is a brief physiotherapeutic assessment, a brief information on the expected course of the condition, and a brief instruction on self-management, including three exercises for daily self-guided therapy.
|
The intervention consists of a brief physiotherapeutic assessment by a short physical performance battery, a brief information on the expected course of the condition and instructions on self-management regarding back friendly behaviour (eg.
respecting the pain, staying active and back friendly movement strategies).
Additionally, three exercises for daily self-guided therapy are included to the intervention: Turning in bed and coming to a sitting position, sit to stand and squats standing in front of a wall.
|
No Intervention: control group
The control group will receive written information on the expected course of the condition, written instructions on self-management and written instructions on exercises for daily self-guided therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oswestry Disability Index (ODI)
Time Frame: At Day 0 and at Day 7 ± 7 days
|
This self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel.
Each topic category is followed by 6 statements describing different potential scenarios in the patient's life relating to the topic.
The patient then checks the statement which most closely resembles their situation.
Each question is scored on a scale of 0-5 with the first statement being zero and indicating the least amount of disability and the last statement is scored 5 indicating most severe disability.
The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100).
Zero is equated with no disability and 100 is the maximum disability possible.
|
At Day 0 and at Day 7 ± 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain Numeric Rating Scale (NRS)
Time Frame: At Day 0, Day 7 ± 7 days, Day 21 ± 3 days, Day 42 ± 3 days
|
The NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain ('0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine"))
|
At Day 0, Day 7 ± 7 days, Day 21 ± 3 days, Day 42 ± 3 days
|
Feasibility of the intervention
Time Frame: At Day 0
|
The questionnaire was completed by the physiotherapist after the intervention and consisted of six questions about the feasibility of the physiotherapeutic intervention.
Each question had a scale of 1 (= no, strongly disagree) to 6 (=yes, strongly agree) for possible answers.
|
At Day 0
|
Patient satisfaction
Time Frame: At Day 7 ± 7 days
|
This self-completed questionnaire contains six questions about patient satisfaction with their ED visit on day 0. Each question could be answered with a score from 0 (not at all) to 10 (very much).
|
At Day 7 ± 7 days
|
Adherence to therapy recommendations
Time Frame: At Day 7 ± 7 days
|
Patients were asked if they were able to adhere to the behavioral and exercise recommendations given to them on Day 0.
|
At Day 7 ± 7 days
|
StarT Back Screening Tool (SBST)
Time Frame: Day 0, Day 7 ± 7 days, Day 42 ± 3 days
|
The SBST categorises back pain patients into 3 categories: low, medium and high risk.
It consists of 9 items, each with a value of 0 or 1 points.
The SBST Score is calculated by summing the points from each question, with a minimum score of 0 points and a maximum score of 9 points.
|
Day 0, Day 7 ± 7 days, Day 42 ± 3 days
|
Oswestry Disability Index (ODI)
Time Frame: Day 21 ± 3 days, Day 42 ± 3 days
|
This self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel.
Each topic category is followed by 6 statements describing different potential scenarios in the patient's life relating to the topic.
The patient then checks the statement which most closely resembles their situation.
Each question is scored on a scale of 0-5 with the first statement being zero and indicating the least amount of disability and the last statement is scored 5 indicating most severe disability.
The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100).
Zero is equated with no disability and 100 is the maximum disability possible.
|
Day 21 ± 3 days, Day 42 ± 3 days
|
Pain medication use
Time Frame: At Day 0, Day 7 ± 7 days, Day 21 ± 3 days, Day 42 ± 3 days
|
Questions about the use of pain medication and how long pain medication have been used.
|
At Day 0, Day 7 ± 7 days, Day 21 ± 3 days, Day 42 ± 3 days
|
Utilization of medical resources
Time Frame: At Day 7 ± 7 days, Day 21 ± 3 days, Day 42 ± 3 days
|
Patients were asked if they had seen a physiotherapist, an emergency department, a general practitioner, a specialist, been hospitalized or had imaging since the last contact.
|
At Day 7 ± 7 days, Day 21 ± 3 days, Day 42 ± 3 days
|
Ability to work
Time Frame: At Day 7 ± 7 days, Day 21 ± 3 days, Day 42 ± 3 days
|
Patients were asked if they were going back to work.
|
At Day 7 ± 7 days, Day 21 ± 3 days, Day 42 ± 3 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Roland Bingisser, Prof. Dr. med., Emergency Department University Hospital Basel
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 5, 2022
Primary Completion (Actual)
June 30, 2023
Study Completion (Actual)
August 11, 2023
Study Registration Dates
First Submitted
November 29, 2021
First Submitted That Met QC Criteria
December 1, 2021
First Posted (Actual)
December 14, 2021
Study Record Updates
Last Update Posted (Actual)
March 28, 2024
Last Update Submitted That Met QC Criteria
March 27, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-02166; am21Bingisser
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lower Back Pain
-
Canandaigua VA Medical CenterFoot Levelers, Inc.; Northeast College of Health SciencesTerminatedBack Pain Lower Back ChronicUnited States
-
University of MichiganRecruiting
-
New York Institute of TechnologyRecruitingChronic Lower Back PainUnited States
-
AppliedVR Inc.Completed
-
Rigshospitalet, DenmarkHerlev HospitalActive, not recruitingLower Back Pain ChronicDenmark
-
Canandaigua VA Medical CenterCompleted
-
Teesside UniversityUnknownLower Back Pain ChronicUnited Kingdom
-
National Taiwan University Hospital Hsin-Chu BranchUnknownConditions for Lower Back Pain Working Nurse
-
Stanford UniversityNot yet recruitingLower Back Pain Chronic
-
Canandaigua VA Medical CenterCompletedChronic Lower Back PainUnited States
Clinical Trials on physiotherapeutic intervention
-
University of Sao Paulo General HospitalCompleted
-
Klaudia MichalcinovaRecruiting
-
University Hospital, Basel, SwitzerlandCompletedFear of FallingSwitzerland
-
Federal University of São PauloWithdrawnChronic Low Back PainBrazil
-
University Hospital, GrenobleCompletedColorectal SurgeryFrance
-
Coxa, Hospital for Joint ReplacementRecruitingOsteo Arthritis KneeFinland
-
Clínica de Hidroterapia e Recuperacao FuncionalIntegrated Faculty of RecifeTerminatedMorquio's Disease
-
Anna OlczakCompletedSpondyloarthritis
-
Kuopio University HospitalCentral Finland Hospital DistrictTerminated
-
vandfysHerlev and Gentofte HospitalCompleted